Whisone AnalystInvestor workspace
MECUREHealthcareUpdated 6h ago

MECURE

MECURE (MECURE) is listed on the Nigerian Exchange in the Healthcare sector, with exposure to Pharmaceutical Preparations. This page brings together the current share price, valuation, dividend context, business summary, and a practical 12-week outlook so you can assess the stock faster.

Sector

Healthcare

Market cap

₦239B

Dividend yield

0.5%

P/E ratio

36.92

Current price

₦59.65

Updated Updated 6h ago

Avoid for Now (12-week)

12-week outlook signal

Research score46/100

P/B

12.04

RSI

30.55

52W high

₦104.00

52W low

₦11.10

Valuation view

Priced richer than peers

Income view

Low income profile

Momentum view

Momentum is balanced

Risk view

Higher volatility risk

Business trend

Latest operating data is available

MECURE operates in the pharmaceutical preparations industry, making and supplying medicines and health-related products. It earns money by selling those products to hospitals, pharmacies, clinics and consumers, and through contracts or distribution agreements.

Investors usually follow MECURE for its dividend profile, valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.

Why this stock stands out

What looks attractive right now.

Return on equity is healthy at roughly 32.6%, which suggests the business is using shareholder capital well.

Latest revenue

₦77.7B

Most recent reported period.

Latest net profit

₦6.46B

Most recent reported period.

ROE

32.6%

Return on equity

Debt / equity

2.79

Lower is usually safer.

P/B ratio

12.04

Useful for book value support.

Dividend yield

0.5%

Current income signal.

Explain the key numbers

P/E ratio

36.92

Price-to-earnings shows what investors pay for every ₦1 of profit. Lower can signal cheaper valuation, but only if profits are reliable.

Compare P/E with peers in the same sector to avoid false signals.

₦0.15

2025-04-22

Payment: 2025-10-03 · Qualification: 2025-04-18

₦0.15

2024-05-20

Payment: 2024-07-03 · Qualification: 2024-05-17

Watch the latest corporate action: Estimated earnings date.
Fundamentals were last updated 0 day(s) ago, so the next filing matters.
Monitor leverage discipline. Debt-to-equity is currently about 2.79x.

Estimated earnings date

2026-04-28

Ex-dividend date

2026-04-24

Price and session

Current price
₦59.65?
Open
₦54.55?
Previous close
₦59.65?
Day range
₦54.55 – ₦59.95?
52-week range
₦11.10 – ₦104.00?

Volume & liquidity

Today volume
154,500?
Average volume
442,621?
Volume vs average
0.35x?
Avg turnover/day
N/A
Tradeability
Hard to exit

Valuation

Market cap
₦239B?
P/E
36.92?
Forward P/E
N/A?
P/B
12.04?
Book value/share
4.96?

Momentum

Beta
1.43?
RSI
30.55?

Income & dividend

EPS
1.62?
Dividend yield
0.5%?
Dividend/share
₦0.15?
Ex-dividend date
2026-04-24?
Dividend records
2?

Latest financials

Revenue
₦77.7B?
Operating profit
₦16.3B?
Net income
₦6.46B
Operating cash flow
N/A?
Capex
-₦10.05?

Event data

Estimated earnings date
2026-04-28

MECURE

MECURE

Price: ₦59.65

P/E: 36.92

Yield: 0.54%

AUSTINLAZ

AUSTINLAZ

Price: ₦3.73

P/E: N/A

Yield: N/A

FIDSON

FIDSON

Price: ₦99.50

P/E: 24.16

Yield: 1.51%

MAYBAKER

MAYBAKER

Price: ₦37.90

P/E: 14.74

Yield: 1.02%

Price updated

0d ago

Fundamentals updated

0d ago

Market cap

₦239B

Open

₦54.55

Previous close

₦59.65

Day range

₦54.55 – ₦59.95

52-week range

₦11.10 – ₦104.00

Volume

154,500

Average volume

442,621

Beta

1.43

RSI

30.55

Latest revenue

₦77.7B

Latest net profit

₦6.46B

Book value / share

4.96

TradeabilityHard to exit

Thin trading conditions can make exits difficult. Keep size modest and use limit orders.

Caution: this stock may not be easy to sell quickly.

Compare mode →AI Expert analysis →

Login to use AI Analyst.

Main risks

Debt is heavy relative to equity, with debt-to-equity around 2.79x.